亚洲日韩欧美综合-亚洲日韩欧美一区二区在线-亚洲日韩欧美视频-亚洲日韩精品欧美一区二区-国产欧美日韩综合

會員登錄|免費注冊|忘記密碼|管理入口 返回主站||保存桌面|手機瀏覽|聯(lián)系方式|購物車
企業(yè)會員第1年

濟南宏方德醫(yī)藥科技有限公司(銷售三部)  

沒有填寫主營業(yè)務(wù)~~

搜索
新聞中心
  • 暫無新聞
產(chǎn)品分類
  • 暫無分類
聯(lián)系方式
  • 聯(lián)系人:王紅
  • 電話:0531-55505896
  • QQ:2659530578
站內(nèi)搜索
 
榮譽資質(zhì)
  • 暫未上傳
友情鏈接
  • 暫無鏈接
80529-93-7
單價 20.00 / 千克對比
銷量 暫無
發(fā)貨 山東濟南市付款后3天內(nèi)
庫存 90000千克起訂1千克
品牌 濟南宏方德
型號 80529-93-7
規(guī)格 千克
過期 長期有效
更新 2014-04-08 09:19
 
詳細信息

中文名稱:
釓噴酸
中文別名:
-
英文名稱:
Gadopentetic acid
英文別名:
Gadopentetic Acid [INN:BAN]; Gadolinium dtpa; Acide gadopentetique; Acide gadopentetique [French]; Acido gadopentetico; Acido gadopentetico [Spanish]; Acidum gadopenteticum; Acidum gadopenteticum [Latin]; Gadolinium diethylenetriamine pentaacetic acid; UNII-K2I13DR72L; Gadolinate(2-), (N,N-bis(2-(bis((carboxy-kappaO)methyl)amino-kappaN)ethyl)glycinato(5-)-kappaN,kappaO)-, dihydrogen; Gadolinate(2-), (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))-, dihydrogen; gadolinium (bis{2-[(carboxylatomethyl)(carboxymethyl)amino]ethyl}amino)acetate - (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol (1:1:2) (non-preferred name); gadolinium hydrogen 2,2',2'',2''',2''''-(ethane-1,2-diylnitrilo)pentaacetate (1:2:1)
CAS號:
80529-93-7
EINECS號:
-
分子式:
C14H20GdN3O10
分子量:
547.5727
InChI:
InChI=1/C14H23N3O10.Gd/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27;/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27);/q;+3/p-3
分子結(jié)構(gòu):
©2025 濟南宏方德醫(yī)藥科技有限公司(銷售三部) 版權(quán)所有   技術(shù)支持:化工網(wǎng)   訪問量:7724  
 
主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |